Related references
Note: Only part of the references are listed.Multiple Stress Signals Activate Mutant p53 In Vivo
Young-Ah Suh et al.
CANCER RESEARCH (2011)
Distinct p53 Transcriptional Programs Dictate Acute DNA-Damage Responses and Tumor Suppression
Colleen A. Brady et al.
CELL (2011)
Biochemical and imaging surveillance in germline TP53 mutation carriers with Li-Fraumeni syndrome: a prospective observational study
Anita Villani et al.
LANCET ONCOLOGY (2011)
A High-Frequency Regulatory Polymorphism in the p53 Pathway Accelerates Tumor Development
Sean M. Post et al.
CANCER CELL (2010)
Oncogenic Role of miR-483-3p at the IGF2/483 Locus
Angelo Veronese et al.
CANCER RESEARCH (2010)
IGFBP7 is a p53-responsive gene specifically silenced in colorectal cancer with CpG island methylator phenotype
Hiromu Suzuki et al.
CARCINOGENESIS (2010)
Mdm2-mediated ubiquitylation: p53 and beyond
J-C Marine et al.
CELL DEATH AND DIFFERENTIATION (2010)
Δ40p53 controls the switch from pluripotency to differentiation by regulating IGF signaling in ESCs
Erica Ungewitter et al.
GENES & DEVELOPMENT (2010)
Effects of MDM2, MDM4 and TP53 Codon 72 Polymorphisms on Cancer Risk in a Cohort Study of Carriers of TP53 Germline Mutations
Shenying Fang et al.
PLOS ONE (2010)
Insulin receptor functionally enhances multistage tumor progression and conveys intrinsic resistance to IGF-1R targeted therapy
Danielle B. Ulanet et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2010)
The regulation of energy metabolism and the IGF-1/mTOR pathways by the p53 protein
Zhaohui Feng et al.
TRENDS IN CELL BIOLOGY (2010)
Longevity regulation in flies: A role for p53
Lawrence A. Donehower
AGING-US (2009)
PTEN and the PI3-Kinase Pathway in Cancer
Nader Chalhoub et al.
ANNUAL REVIEW OF PATHOLOGY-MECHANISMS OF DISEASE (2009)
Gli2 and p53 Cooperate to Regulate IGFBP-3-Mediated Chondrocyte Apoptosis in the Progression from Benign to Malignant Cartilage Tumors
Louisa Ho et al.
CANCER CELL (2009)
Insulin Receptor Isoform A and Insulin-like Growth Factor II as Additional Treatment Targets in Human Osteosarcoma
Sofia Avnet et al.
CANCER RESEARCH (2009)
Blinded by the Light: The Growing Complexity of p53
Karen H. Vousden et al.
CELL (2009)
H19 acts as a trans regulator of the imprinted gene network controlling growth in mice
Anne Gabory et al.
DEVELOPMENT (2009)
Preclinical Targeting of the Type I Insulin-Like Growth Factor Receptor in Adrenocortical Carcinoma
Ferdous M. Barlaskar et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2009)
Pscan: finding over-represented transcription factor binding site motifs in sequences from co-regulated or co-expressed genes
Federico Zambelli et al.
NUCLEIC ACIDS RESEARCH (2009)
Timed Somatic Deletion of p53 in Mice Reveals Age-Associated Differences in Tumor Progression
George Hinkal et al.
PLOS ONE (2009)
The expanding universe of p53 targets
Daniel Menendez et al.
NATURE REVIEWS CANCER (2009)
lumi:: a pipeline for processing Illumina microarray
Pan Du et al.
BIOINFORMATICS (2008)
p53 target genes Sestrin1 and Sestrin2 connect genotoxic stress and mTOR signaling
Andrei V. Budanov et al.
CELL (2008)
Somatically acquired hypomethylation of IGF2 in breast and colorectal cancer
Yoko Ito et al.
HUMAN MOLECULAR GENETICS (2008)
Transcriptional control of human p53-regulated genes
Todd Riley et al.
NATURE REVIEWS MOLECULAR CELL BIOLOGY (2008)
The H19 locus acts in vivo as a tumor suppressor
Tomomi Yoshimizu et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2008)
Dnmt3b promotes tumorigenesis in vivo by gene-specific de novo methylation and transcriptional silencing
Heinz G. Linhart et al.
GENES & DEVELOPMENT (2007)
The regulation of AMPK β1, TSC2, and PTEN expression by p53:: Stress, cell and tissue specificity, and the role of these gene products in modulating the IGF-1-AKT-mTOR pathways
Zhaohui Feng et al.
CANCER RESEARCH (2007)
The imprinted H19 noncoding RNA is a primary microRNA precursor
Xuezhong Cai et al.
RNA (2007)
Restoration of p53 function leads to tumour regression in vivo
Andrea Ventura et al.
NATURE (2007)
Senescence and tumour clearance is triggered by p53 restoration in murine liver carcinomas
Wen Xue et al.
NATURE (2007)
Respiratory distress and neonatal lethality in mice lacking Golgi α1,2-mannosidase IB involved in N-glycan maturation
Linda O. Tremblay et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2007)
Modeling the therapeutic efficacy of p53 restoration in tumors
Carla P. Martins et al.
CELL (2006)
Igf2 deficiency results in delayed lung development at the end of gestation
Delia Silva et al.
ENDOCRINOLOGY (2006)
Insulin-like growth factor factor binding protein-2 is a novel mediator of p53 inhibition of insulin-like growth factor signaling
Adda Grimberg et al.
CANCER BIOLOGY & THERAPY (2006)
Joint effects of germ-line p53 mutation and sex on cancer risk in Li-Fraumeni syndrome
Chih-Chieh Wu et al.
CANCER RESEARCH (2006)
Kinetics of insulin-like growth factor II (IGF-II) interaction with domain 11 of the human IGF-II/mannose 6-phosphate receptor: Function of CD and AB loop solvent-exposed residues
Oliver J. Zaccheo et al.
JOURNAL OF MOLECULAR BIOLOGY (2006)
The expression profile of microRNAs in mouse embryos
J Mineno et al.
NUCLEIC ACIDS RESEARCH (2006)
Deregulation of DNA methyltransferases and loss of parental methylation at the insulin-like growth factor II (Igf2)/H19 loci in p53 knockout mice prior to tumor development
IY Park et al.
JOURNAL OF CELLULAR BIOCHEMISTRY (2005)
Insulin-like growth factor ligands, receptors, and binding proteins in cancer
E Foulstone et al.
JOURNAL OF PATHOLOGY (2005)
Gain of function of a p53 hot spot mutation in a mouse model of Li-Fraumeni syndrome
GA Lang et al.
CELL (2004)
Mutant p53 gain of function in two mouse models of Li-Fraumeni syndrome
KP Olive et al.
CELL (2004)
DNA damage induces p53-dependent BRCA1 nuclear export
ZH Feng et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2004)
A single nucleotide polymorphism in the MDM2 promoter attenuates the p53 tumor suppressor pathway and accelerates tumor formation in humans
GL Bond et al.
CELL (2004)
Bioconductor: open software development for computational biology and bioinformatics
RC Gentleman et al.
GENOME BIOLOGY (2004)
Fibronectin requirement in branching morphogenesis
T Sakai et al.
NATURE (2003)
Induction of tumors in mice by genomic hypomethylation
F Gaudet et al.
SCIENCE (2003)
Mannose 6-phosphate receptors: New twists in the tale
P Ghosh et al.
NATURE REVIEWS MOLECULAR CELL BIOLOGY (2003)
REDD1, a developmentally regulated transcriptional target of p63 and p53, links p63 to regulation of reactive oxygen species
LW Ellisen et al.
MOLECULAR CELL (2002)
Does p53 affect organismal aging?
LA Donehower
JOURNAL OF CELLULAR PHYSIOLOGY (2002)
Elevated levels of IGF-1 receptor convey invasive and metastatic capability in a mouse model of pancreatic islet tumorigenesis
T Lopez et al.
CANCER CELL (2002)
The IARC TP53 database: New Online mutation analysis and recommendations to users
M Olivier et al.
HUMAN MUTATION (2002)
A phosphatidylinositol 3-kinase/Akt pathway promotes translocation of Mdm2 from the cytoplasm to the nucleus
LD Mayo et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2001)
Regulation of PTEN transcription by p53
V Stambolic et al.
MOLECULAR CELL (2001)
Significance analysis of microarrays applied to the ionizing radiation response
VG Tusher et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2001)
Activation of the insulin-like growth factor II transcription by aflatoxin B1 induced p53 mutant 249 is caused by activation of transcription complexes; implications for a gain-of-function during the formation of hepatocellular carcinoma
YI Lee et al.
ONCOGENE (2000)
Share Paper
